Verfahren und Vorrichtungen zur Beurteilung von Pankreaskrebs
Anmelder: Ludwig-Maximilians-Universität München, in Vertretung des Freistaates Bayern 🇩🇪
Details
- Veröffentlichungs-Nr.
- EP4786983
- Anmeldetag
- 3. Februar 2025
- Veröffentlichung
- 5. August 2026
- Rechtsraum
- EP
Abstract
The present invention relates to a method for assessing pancreatic cancer in a subject, said method comprising (a) determining the biomarkers Ceramide (d18:1;C24:0), Lysophosphatidylethanolamine (C18:0), Phosphatidylethanolamine (C18:0, C22:6), Sphingomyelin (d17:1; C16:0), and CA19.9 in a sample from said subject; (b) comparing the biomarkers determined in step (a) to at least one corresponding reference; and (c) assessing pancreatic cancer in said subject based on said comparing in step (b). The present invention further relates to a computer-implemented training method of training at least one trainable model for assessing pancreatic cancer, to an automated machine learning model, and to a system related thereto.
Anmelder
- Firma
- Ludwig-Maximilians-Universität München, in Vertretung des Freistaates Bayern
- Land
- 🇩🇪 Deutschland